From urban hospitals and private clinics to rural outreach and home-based care, our portable, "on-the-edge" AI (offline AI) devices bring standard screening for DR, glaucoma, and AMD to every setting—regardless of infrastructure.
Patients Screened
Clinical Publications
AI Sensitivity
Devices Deployed
Delivering AI-powered eye screening solutions across diverse healthcare settings worldwide
Empowering general practitioners with portable screening tools for early disease detection at point-of-care
AI-powered retinal imaging, no dilation needed
Bringing comprehensive eye examinations directly to patients in their homes with mobile screening kits
Complete portable eye clinic, bedside ready
Enabling large-scale screening programs in remote areas with durable, field-ready diagnostic equipment
Field-ready kit for mass screening camps
Enabling national screening programmes and NCD control initiatives — scalable, reportable, deployable across entire health systems
AI Screening Suite (MediosHI) · Remidio Connect Analytics
Rapid bedside ocular assessment to triage patient and visual apperance identify urgent eye conditions without delaying care
Bedside retinal imaging in under 60 seconds
Answer 3 quick questions — our team will reach out with solutions built for your setting.
From NHS trusts to national NCD programmes — Remidio is deployed across diverse healthcare systems worldwide.
Our team reviews every submission and connects you with the right solution specialist — no spam, ever.
Bringing preventive retinal screening to where your patients already are
Make every visit a step towards better eye health — offer preventive retinal screening right at your store, no specialist needed
Detect early signs before symptoms appear — no referral, no specialist required
Request a DemoClose the gap in diabetic patient care — screen for Diabetic Retinopathy during their routine visit, right in your clinic
Every diabetic patient is at risk.
Catch it early — no referral, no eye specialist required
From AI-powered diagnostics to complete mobile & remote clinic solutions, our platform adapts to your workflow—whether you're screening thousands in urban hospitals or reaching remote villages.
Insta FOP NM 10 — DR, Glaucoma & AMD screening
Insta PSL D20 — Anterior segment examination
InstaRef R20 — Accurate refraction measurement
Mobile & Remote Comprehensive Kit
Insta PM 1 — Corneal thickness measurement
InstaZ — Next Gen Automated fundus imaging with offline AI, no dilation
Insta KC — Keratoconus screening & monitoring
Pristine 5.0 — Advanced wide-field retinal imaging
Pristine OBM 12 — Built for the Myopia Clinic.
Neubo 130 — Paediatric fundus camera with offline ROP AI
Smartphone-based slit lamp imaging (seamless documentation, secure data capture, and easy integration with existing digital records and tele-consultation workflows — without disrupting current infrastructure.
Surgical documentation & live streaming
Our On The Edge AI (Offline AI) analyses retinal images to detect chronic eye diseases at scale. Whether you already own a Remidio device or use any other fundus camera — our AI platform integrates seamlessly to deliver clinical-grade insights instantly
Run mass screening programmes or analyse existing patient image databases to understand population health patterns.
Automate disease grading to reduce waiting times, support your ophthalmologists, and screen more patients daily
Deploy AI in low-resource settings to triage patients efficiently — even without specialist availability on-site.
Screens DR + Glaucoma + AMD
Screens Diabetic Retinopathy (DR)
Screens Glaucoma Risk Grading
Screens AMD for Macular Conditions
Screens ROP in Premature Infants
Remote Diagnosis & Referral
Peer-reviewed publications, validation studies, and white papers documenting Remidio’s clinical accuracy and real-world impact across 16 million+ patient screenings globally.
Discover how portable AI-powered screening technology is revolutionising access to comprehensive eye care throughout European communities, from rural outreach to urban clinics.
13 September, 2022
13 July, 2022
13 December, 2021
1 December, 2021
29 November, 2021
